These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25271091)

  • 1. Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study.
    Oh S; Shida T; Yamagishi K; Tanaka K; So R; Tsujimoto T; Shoda J
    Hepatology; 2015 Apr; 61(4):1205-15. PubMed ID: 25271091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.
    Oh S; Tanaka K; Tsujimoto T; So R; Shida T; Shoda J
    Metab Syndr Relat Disord; 2014 Jun; 12(5):290-8. PubMed ID: 24689911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise reduces inflammation and oxidative stress in obesity-related liver diseases.
    Oh S; Tanaka K; Warabi E; Shoda J
    Med Sci Sports Exerc; 2013 Dec; 45(12):2214-22. PubMed ID: 23698242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD.
    Oh S; Tsujimoto T; Kim B; Uchida F; Suzuki H; Iizumi S; Isobe T; Sakae T; Tanaka K; Shoda J
    JHEP Rep; 2021 Jun; 3(3):100253. PubMed ID: 33898958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance.
    Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
    Liver Int; 2015 Mar; 35(3):944-52. PubMed ID: 24684289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?
    Montesi L; Caselli C; Centis E; Nuccitelli C; Moscatiello S; Suppini A; Marchesini G
    World J Gastroenterol; 2014 Aug; 20(29):10128-36. PubMed ID: 25110440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
    Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
    Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sustained decreases in sedentary time and increases in physical activity on liver enzymes and indices in type 2 diabetes.
    Haxhi J; Vitale M; Mattia L; Giuliani C; Sacchetti M; Orlando G; Iacobini C; Menini S; Zanuso S; Nicolucci A; Balducci S; Pugliese G
    Front Endocrinol (Lausanne); 2024; 15():1393859. PubMed ID: 38854689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training.
    Linden MA; Fletcher JA; Morris EM; Meers GM; Laughlin MH; Booth FW; Sowers JR; Ibdah JA; Thyfault JP; Rector RS
    Med Sci Sports Exerc; 2015 Mar; 47(3):556-67. PubMed ID: 24983336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended levels of physical activity to avoid adiposity in Spanish children.
    Laguna M; Ruiz JR; Lara MT; Aznar S
    Pediatr Obes; 2013 Feb; 8(1):62-9. PubMed ID: 22961693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease.
    Oh S; So R; Shida T; Matsuo T; Kim B; Akiyama K; Isobe T; Okamoto Y; Tanaka K; Shoda J
    Sci Rep; 2017 Feb; 7():43029. PubMed ID: 28223710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Garlic essential oil protects against obesity-triggered nonalcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress.
    Lai YS; Chen WC; Ho CT; Lu KH; Lin SH; Tseng HC; Lin SY; Sheen LY
    J Agric Food Chem; 2014 Jun; 62(25):5897-906. PubMed ID: 24857364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats.
    Kapravelou G; Martínez R; Andrade AM; Nebot E; Camiletti-Moirón D; Aparicio VA; Lopez-Jurado M; Aranda P; Arrebola F; Fernandez-Segura E; Bermano G; Goua M; Galisteo M; Porres JM
    Appl Physiol Nutr Metab; 2015 Dec; 40(12):1242-52. PubMed ID: 26509584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease.
    Rezende RE; Duarte SM; Stefano JT; Roschel H; Gualano B; de Sá Pinto AL; Vezozzo DC; Carrilho FJ; Oliveira CP
    Menopause; 2016 Aug; 23(8):876-83. PubMed ID: 27458060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
    Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: A 1-year follow-up study.
    Zhang HJ; Pan LL; Ma ZM; Chen Z; Huang ZF; Sun Q; Lu Y; Han CK; Lin MZ; Li XJ; Yang SY; Li XY
    Diabetes Obes Metab; 2017 Feb; 19(2):284-289. PubMed ID: 27761987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.